Fri, Aug 22, 2014, 11:34 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Prothena Corporation plc Message Board

rayrhc 5 posts  |  Last Activity: Feb 10, 2014 8:05 AM Member since: Mar 6, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • AMTecH was formed to design, create, and test -- both virtually and physically -- a wide variety of electromechanical and biomedical components, systems and processes. Currently, the group is working on projects ranging from printed circuit boards for automobiles and aircraft to replacement parts for damaged and failing human organs and tissue, says Tim Marler, AMTecH co-director.

    "Electromechanical systems are one of two current branches of the AMTecHgroup," he says. "We want to simulate, analyze and test printed circuit boards and assemblies, because they are used in a wide range of products from missiles to power plants to cell phones. "The second branch of the group involves biomanufacturing and is led by my colleague and AMTecH co-director Ibrahim Ozbolat, assistant professor of mechanical and industrial engineering," says Marler. "The long-term goal of this branch is to create functioning human organs some five or 10 years from now. This is not far-fetched."

    Using its facilities for engineering living tissue systems, the Biomanufacturing Laboratory at CCAD is working to develop and refine various 3D printing processes required for organ and tissue fabrication, Ozbolat says.

    "One of the most promising research activities is bioprinting a glucose-sensitive pancreatic organ that can be grown in a lab and transplanted anywhere inside the body to regulate the glucose level of blood," says Ozbolat. He adds that the 3D printing, as well as virtual electronic manufacturing, being conducted at AMTecH are done nowhere else in Iowa.

    In fact, the multi-arm bio printer being used in the lab is unique. Ozbolat and Howard Chen, a UI doctoral student in industrial engineering, designed it and Chen built it. It turns out that managing multiple arms without having them collide with one another is difficult enough that other printers used in other parts of the world avoid the problem by using simpler designs calling for single-arm printing. As Chen continues to refine his

  • Reply to

    Accepted into trial

    by rayrhc Sep 9, 2013 8:47 PM
    rayrhc rayrhc Oct 20, 2013 4:33 PM Flag

    11 people already started in trial atNYC site, son starts trial with first dosage on Oct 23. Dr. Landau reports no toxicity problems with the first 11 patients to this point. I know it is still early but sounds very promising.

  • Reply to

    raymond and alex are

    by superpress Sep 16, 2013 7:16 PM
    rayrhc rayrhc Sep 16, 2013 7:19 PM Flag

    Suzie doesn't have the balls to short so she took theirs

  • Reply to

    Accepted into trial

    by rayrhc Sep 9, 2013 8:47 PM
    rayrhc rayrhc Sep 9, 2013 9:13 PM Flag

    BTW, he was accepted at the NYC site. I cannot get it to accept the URL but if you go to Clinical trials dot gov you can do a search for the trial

  • Phase I, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis. My son has Amyloidosis and on Friday got notice of acceptance. I bought this stock after it was spun off from ELN @ 6.24 because of this drug. It looks like this will be a big winner if drug works. This disease is a very debilitating disease with those who get it have usually very little chance of living more than 2yrs. Hope it can be successful for my sons sake. When I told his doctors about this trial they didn't know anything about it. They were excited about it after doing their research. I know the doctor I talked to was buying this stock and I believe its move up is because of passing the word around. Doctor actually thanked me for info because he said they don't ever get info about trials and he is a specialist on Amyloidosis at University of Pennsylvania. The only thing is that it will be another 3 to 4 years before trials end. Sorry I didn't buy more, never thought it would move up this quick. Good luck to all.

21.49+0.24(+1.13%)Aug 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Keurig Green Mountain, Inc.
NasdaqGSFri, Aug 22, 2014 4:00 PM EDT, Inc
NYSEFri, Aug 22, 2014 4:00 PM EDT